Metabolic stability of the fucose in rat transferrin  by Regoeczi, Erwin & Chindemi, Paul A.
Volume 222, number 2, 271-274 FEB 05164 October 1987 
Metabolic stability of the fucose in rat transferrin 
Erwin Regoeczi and Paul A. Chindemi 
Department of Pathology, McMaster University Health Sciences Centre, Hamilton, Ontario L8N 3Z5, Canada 
Received 15 June 1987; revised version received 17 July 1987 
The metabolic behaviour of the chitobiose core fucose that is a natural constituent of a large proportion 
of rat transferrin molecules was studied in rats comparatively to that of the polypeptide portion of the glyco- 
protein by using appropriate labels ([aH]fucose and 125I) and affinity chromatographic te hniques (lentil- 
Sepharose). No evidence was obtained to suggest that this residue is cleaved from the glycan in significant 
amounts before removal of the entire glycoprotein for catabolism. Similarly, p4C]fucose linked to GlcNAc 
residues in the antennae of human asialotransferrin was being eliminated in pigeons at the same rate as 
the polypeptide itself. It is concluded that in spite of transferrin's exposure to the cellular milieu, the fate 
of its fucose is distinctly different from that of the same in plasma membrane glycoproteins. 
Fucose; Glycoprotein metabolism; Transferrin 
1. INTRODUCTION 
Precursor fucose, as shown by several investiga- 
tions [1-4], is efficiently incorporated by the rat 
liver into newly synthesized membrane glycopro- 
teins. An intriguing feature of fucose (and sialic 
acid) in hepatic membrane glycoproteins is its 
short half-life as compared with that of the peptide 
moiety. This observation was first made for dipep- 
tidylpeptidase IV [5], and then extended over five 
additional individual glycoproteins [6] by Reutter 
and co-workers [7,8]. Hepatoma cell-membrane 
glycoproteins, whether in situ or transferred to 
fibroblasts, exhibit an analogous behaviour [9]. 
There is as yet no patent explanation for this 
phenomenon. Exposure of membrane glycoprotein 
glycans to subcellular hydrolases during endocytic 
passages, possibly in a prelysosomal compartment 
[8], seems a plausible hypothesis [6,9]. 
A plasma protein which is known to undergo 
repeated iacytic cycles is transferrin [10] and, by 
so doing, it might become xposed to a similar in- 
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tracellular microenvironment as membrane 
glycoproteins do periodically. The question thus 
raised is: are the sugars that had been found to be 
short-lived in membrane glycoproteins, also 
prematurely removed from transferrin? 
By employing lentil-lectin chromatography, 
which is specific for the presence of an a-linked 
fucose attached to the asparagine-linked N- 
acetylglucosamine of the chitobiose core in com- 
plex glycans [11], we found recently that approx- 
imately one rat transferrin molecule out of four is 
fucosylated [12]. This observation provided a 
means of investigating whether transferrin fucose 
and polypeptide are being eliminated simul- 
taneously. 
2. MATERIALS AND METHODS 
2.1. Isolation and preparation o f  tracer proteins 
Rat transferrin (rTf) of the type that contains a 
standard biantennary glycan was isolated as in [13] 
from the plasmas of normal female Sprague- 
Dawley rats and from a rat which had received 
[3H]fucose. The tracer (500/~Ci, 55 Ci/mmol, ICN 
Radiochemicals, Irvine, CA) was injected i.p. and 
the recipient exsanguinated 6 h later. Fucose- 
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containing and fucose-free forms of rTf were 
separated by affinity chromatography on a column 
(1 x 5 cm) of lentil-Sepharose (Sigma, St. Louis, 
MO) as before [13]. Samples (50-100/2g) of either 
form of rTf were labelled with 125I (New England 
Nuclear, Boston, MA) by using tetrachloro- 
glycoluril according to specifications given else- 
where [14]. Human asialotransferrin, the type 
possessing two biantennary glycans, was fuco- 
sylated in each of the four branch GlcNAc by in- 
cubation with GDP[laClfucose and te(l-3)fucosyl- 
transferase from human milk under conditions 
given by Prieels et al. [15]. 
2.2. Experimental procedures 
Adult rats (200-250 g) were used for studies 
with rTf and adult pigeons (390-480 g) for those 
with human asialotransferrin. Quantities of 
radioactivities injected were determined gravi- 
metrically [13]. The protein doses per 100 g body 
wt were of the order of 10-20/2g for 125I-, 
170-190/2g for 3H- and 90-100/2g for 14C-labelled 
preparations. In experiments with 125I, the 
animals' drinking water was supplemented with 
NaI (0.005%, w/v). Small (20-50/21) venous 
plasma samples, anticoagulated with heparin, were 
obtained at intervals. They were brought o a stan- 
dard volume and assayed in duplicate. 125I was 
counted in a Packard model 5986 multichannel 
analyzer. Samples containing ~H or 14C were 
measured ina Beckman LS-230 counter before and 
after internal standardization. Total-body radia- 
tion was measured in an instrument described 
elsewhere [16]. 
3. RESULTS AND DISCUSSION 
3.1. General 
6 h after the i.p. administration f [~H]fucose to 
a rat, 8% of the plasma radioactivity was still in a 
dialyzable form. Over 80% of the tracer that had 
been incorporated in plasma glycoproteins was 
bound by lentil-Sepharose, and a high proportion 
(70-80%) of the bound fraction represented 
fucosylated rTf. 
3.2. Observations with rTf 
Two rats received rTf biosynthetically abelled 
with [3H]fucose and another two fucose- 
containing (i.e. lentil-binding) rTf labelled with 
125I. Data from one of these paired experiments are 
summarized in fig. 1, and they show that the labels 
representing the polypeptide chain and the attach- 
ed fucose were being eliminated, within experimen- 
tal error, at identical rates. The finding was the 
same in the other pair of rats. 
In another set of studies, fucose-free and fucose- 
containing rTf preparations were labelled with 125I 
for separate injections in two rats each. 1 h before 
administering the dose as well as 24 h later, the 
animals were given 0.75 mg Fe/100 g body wt as 
the nitrilotriacetate complex. (This treatment 
saturates circulating rTf with Fe for hours and 
thereby promotes transcellular movement of the 
protein [17].) Plasma samples (0.1 ml) obtained 24 
and 48 h after injecting the labelled proteins were 
chromatographed on lentil-Sepharose in order to 
determine whether there were any time-dependent 
changes in the affinity behaviour of rTf still in the 
circulation. No portion of the fucose-free rTf ac- 
quired any affinity for the lectin during the obser- 
vation period. However, the proportion of 
molecules lacking affinity for lentil in the fucose- 
containing preparation i creased from 0.86% in 
the dose solution to 1.55% after 24 h and to 2.51% 
after 48 h. 
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Fig.l. Comparison of the catabolic rates of the fucose 
and polypeptide moieties of rTf in two rats. One rat, 
denoted by circles, received at 0 h biosynthetically 
labelled [3Hlfucose-rTf (4.4 × 105 dpm), and the other, 
denoted by triangles, lentil-positive rTf labelled with 125I 
(approx. 60/zCi). The upper curve represents 125I total- 
body radiation whereas the lower one concentrations of 
3H activity per ml of plasma. Half-lives were calculated 
by semilogarithmic regression from the single- 
exponential sections of the curves. 
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These findings suggest hat the fucose in rTf, 
unlike in hepatic plasma membrane glycoproteins, 
is basically a steady constituent: The fucose-free 
form of the glycan does not acquire any fucose 
post-secretionally, and only a minor portion of rTf 
that possesses fucose initially loses it subsequently. 
A loss of <2070 in 48 h seems biologically insignifi- 
cant when the metabolic half-life of the whole 
glycoprotein molecule is taken into account. The 
intermediate position of rTf with respect o fucose 
content between human (not fucosylated [18]) and 
porcine (fully fucosylated [18]) transferrins is 
therefore biosynthetic in its origin. 
Interpretation of the data in fig. 1 would suffer 
if [3H]fucose hydrolyzed from the injected rTf 
were reutilized to a large extent during de novo 
synthesis of rTf. However, in the light of cellular 
fucose metabolism [19], this seems unlikely. An 
alternative source of error, namely denaturation of
rTf on iodination [14], would have been detectable 
from the shape of total-body radiation curves [20]. 
3.3. Observations with fucosylated human asialo- 
transferrin 
One conceivable xplanation of the unequal 
stability of fucose in rTf  and plasmalemma 
glycoproteins could be a difference in attachment 
sites, considering that fucose in the chitobiose 
core, as in rTf, is much less accessible to fucosidase 
than that in the antennae [21]. To explore this, the 
elimination of [lac]fucose linked or(l-3) to GIcNAc 
residues of the antennae of human asialotransfer- 
rin was investigated in three pairs of pigeons com- 
paratively to the degradation of the peptide 
moiety. (Avian species lack a hepatic recognition 
system for asialoglycoproteins [22].) No significant 
difference was found between the disappearance 
rates of the sugar and protein labels (fig.2). 
The present studies show that the unique 
behaviour of fucose in hepatic membrane 
glycoproteins, outlined in section 1 cannot be 
simulated by rTf. Co-ordinate turnover of the car- 
bohydrate and peptidyl portions was also reported 
for fl-glucuronidase and fl-galactosidase in mouse 
peritoneal macrophages [23]. It is unclear at pre- 
sent whether the stable character of rTf fucose is 
due to a difference in the subcellular routing of rTf  
or to the number of transcellular cycles rTf ac- 
complishes by comparison to the structures having 
short-lived terminal sugars. Finding the answer 
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Fig.2. Comparison of the catabolic rates of the fucose 
and polypeptide moieties of human asialotransferrin in 
two pigeons. One pigeon, denoted by circles, received at 
0 h ~25I-labelled fucosylated human asialotransferrin 
(16/~Ci). The other pigeon, denoted by triangles, was 
given the same protein, not iodinated but traced by its 
[14C]fucose content (1.56 × 105 dpm). Points represent 
concentrations of 14C and protein-bound 1231 per ml of 
plasma, expressed as percentages of the first samples 
obtained 5 min after injection. The initially 
multiexponential ppearance of the curve reflects 
equilibration of the dose with the extravascular space 
[20]. The slope and half-life refer to the experiment with 
1251. 
may cast new light on intricate details of the in- 
tracellular handling of glycoproteins in general. 
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